Indian Journal of Nephrology About us |  Subscription |  e-Alerts  | Feedback | Login   
  Print this page Email this page   Small font sizeDefault font sizeIncrease font size
 Home | Current Issue | Archives| Ahead of print | Search |Instructions |  Editorial Board  

Users Online:171

Official publication of the Indian Society of Nephrology

Ahead of print articles
LETTER TO EDITOR
Ahead of print publication  

Hemolytic uremic syndrome associated with Plasmodium vivax malaria successfully treated with plasma exchange


 Department of Paediatrics, Al Kindy College of Medicine, Baghdad University, Baghdad, Iraq

Date of Web Publication13-Feb-2014

Correspondence Address:
MD Al-Mendalawi,
Department of Paediatrics, Al-Kindy College of Medicine, Baghdad University, P. O. Box 55302, Baghdad Post Office, Baghdad
Iraq
Login to access the Email id

Source of Support: None, Conflict of Interest: None



How to cite this URL:
Al-Mendalawi M D. Hemolytic uremic syndrome associated with Plasmodium vivax malaria successfully treated with plasma exchange. Indian J Nephrol [Epub ahead of print] [cited 2017 Jul 27]. Available from: http://www.indianjnephrol.org/preprintarticle.asp?id=133042

Sir,

The two recently published case reports, [2] have thrown the light on the association of Plasmodium vivax malaria with hemolytic uremic syndrome (HUS). This unusual association is novel and indicates potential virulence of the parasite. However, such association is debatable at best. The diagnosis of HUS in the report of Keskar et al. [1] was based on the presence of high serum lactate dehydrogenase, elevated reticulocyte count and presence of schistocytes on peripheral blood smear. Furthermore, the kidney biopsy showed features of thrombotic microangiopathy (TMA). I presume that the aforementioned constellation is actually pertained to a group of pathological conditions termed TMAs rather than merely HUS. It is well-known that TMAs might be associated with many infections, bone marrow transplantation, pregnancy, systemic vacuities and certain drugs. They include several phenotypes, most prominently are thrombotic thrombocytopenic purpura (TTP), Shiga toxin-producing Escherichia coli HUS and atypical hemolytic uremic syndrome (AHUS). The diagnostic criteria of TTP are based on the clinical features of neurologic and renal dysfunction along with anemia and thrombocytopenia, low a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) activity and the presence of ultra-large von Willebrand factor. In contrast, AHUS might appear as a consequence of mutations related to the alternative pathway for the compliment system. It can be distinguished from TTP on the basis of an ADAMTS13 enzyme activity measurement. [3],[4] It is essential that HUS, AHUS and TTP be differentiated quickly, as they require markedly divergent treatments. Plasmapheresis in HUS is not efficient. Alternatively, plasma therapy and in some cases dialysis are used. The prompt treatment for most cases of AHUS and TTP is with plasma exchange initially and monoclonal therapy (rituximab in TTP and eculizumab in AHUS) as the mainstay of therapy. [5] I presume that Keskar et al., [1] didn't consider the appropriate diagnostic tools, probably due to technical difficulties and limited financial resources, to exactly determine which TMA variant was associated with P. vivax malaria in their studied patient and hence, to implement the appropriate therapy.

 
  References Top

1.Keskar VS, Jamale TE, Hase NK. Hemolytic uremic syndrome associated with Plasmodium vivax malaria successfully treated with plasma exchange. Indian J Nephrol 2014;24:35-7.  Back to cited text no. 1
[PUBMED]  Medknow Journal  
2.Patel MP, Kute VB, Gumber MR, Gera DN, Shah PR, Patel HV, et al. Plasmodium vivax malaria presenting as hemolytic uremic syndrome. Indian J Nephrol 2013;23:74-5.  Back to cited text no. 2
[PUBMED]  Medknow Journal  
3.Laurence J. Atypical hemolytic uremic syndrome (aHUS): Making the diagnosis. Clin Adv Hematol Oncol 2012;10 10 Suppl 17:1-12.  Back to cited text no. 3
    
4.Shenkman B, Einav Y. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: Diagnosis and classification. Autoimmun Rev 2014:pii: S1568-9972 (14) 00016-0  Back to cited text no. 4
    
5.Scully M, Goodship T. How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome. Br J Haematol 2014 Jan 6. doi: 10.1111/bjh.12718. [Epub ahead of print].  Back to cited text no. 5
    




 

 
Top
 
 
  Search
 
  

 
  In this article
   References

 Article Access Statistics
    Viewed786    
    PDF Downloaded37    

Recommend this journal

Indian Journal of Nephrology
Published by Wolters Kluwer - Medknow
Online since 20th Sept '07